CAPZA3

 

Full name: capping actin protein of muscle Z-line subunit alpha 3 Alias Symbol: Gsg3|CAPPA3
Type: protein-coding gene Cytoband: 12p12.3
Entrez ID: 93661 HGNC ID: HGNC:24205 Ensembl Gene: ENSG00000177938 OMIM ID: 608722
Drug and gene relationship at DGIdb

 

Expression of CAPZA3:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 CAPZA3 93661 236888_at -0.0322 0.9245
GSE26886 CAPZA3 93661 236888_at -0.0336 0.7936
GSE45670 CAPZA3 93661 236888_at 0.0700 0.5215
GSE53622 CAPZA3 93661 45593 -1.1357 0.0000
GSE53624 CAPZA3 93661 45593 -0.8472 0.0000
GSE63941 CAPZA3 93661 236888_at 0.2849 0.0617
GSE77861 CAPZA3 93661 236888_at -0.0108 0.9325
TCGA CAPZA3 93661 RNAseq -3.4068 0.0000

Upregulated datasets: 0; Downregulated datasets: 2.  


 

Survival by CAPZA3 expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of CAPZA3:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 CAPZA3 93661 7 2 21
GSE20123 CAPZA3 93661 7 2 21
GSE43470 CAPZA3 93661 8 4 31
GSE46452 CAPZA3 93661 10 1 48
GSE47630 CAPZA3 93661 14 2 24
GSE54993 CAPZA3 93661 1 9 60
GSE54994 CAPZA3 93661 11 2 40
GSE60625 CAPZA3 93661 0 1 10
GSE74703 CAPZA3 93661 8 3 25
GSE74704 CAPZA3 93661 6 1 13
TCGA CAPZA3 93661 41 6 49

Total number of gains: 113; Total number of losses: 33; Total Number of normals: 342.  


 

Somatic mutations of CAPZA3:

 

Generating mutation plots.

 

Highly correlated genes for CAPZA3:

 

Showing top 20/28 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
CAPZA3MAGEC30.685038303
CAPZA3KLKB10.662144303
CAPZA3NCR10.660911303
CAPZA3CRX0.656918303
CAPZA3CDRT15L20.645223303
CAPZA3CCDC500.634202303
CAPZA3C19orf570.608731404
CAPZA3SIK10.584047303
CAPZA3ROGDI0.583731403
CAPZA3MASP20.578854403
CAPZA3SFRP50.578067403
CAPZA3SPHKAP0.575179403
CAPZA3ARID5A0.570779403
CAPZA3SHBG0.569544403
CAPZA3SLIT10.567322403
CAPZA3TTR0.556888403
CAPZA3CMTM10.556146403
CAPZA3KRT130.553901404
CAPZA3LDHAL6B0.553752303
CAPZA3MIXL10.55246403

For details and further investigation, click here